GL1X · GenesisL1 explorer

MolNFT v1 · #79314 · protein

ISPH:LIGAND mutants - wt 70SEC

3SZL · 4-hydroxy-3-methylbut-2-enyl diphosphate reductase: “ISPH:LIGAND mutants - wt 70SEC”. X-ray diffraction, 2 ligands (SF4, H6P), 7 pockets (best druggability 0.81). MolNFT v1 #79314 on GenesisL1: 3D structure, binding sites and…

PDB
3SZL
Type
protein
Length
619 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
4-hydroxy-3-methylbut-2-enyl diphosphate reductase
EC
1.17.1.2
UniProt
P62623
Ligands
SF4, H6P
Pockets
7 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A4-hydroxy-3-methylbut-2-enyl diphosphate reductase (EC 1.17.1.2)protein30942% helix, 18% strandP62623
B4-hydroxy-3-methylbut-2-enyl diphosphate reductase (EC 1.17.1.2)protein31042% helix, 18% strandP62623

Ligands and binding sites

  • SF4 · Iron/sulfur cluster · ligand · 2 copies · chains A, B
  • H6P · (2E)-4-hydroxy-3-methylbut-2-en-1-yl trihydrogen diphosphate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11430.810.9826SF4, H6P
21390.790.9729SF4, H6P
39010.790.8159empty
42180.590.8135empty
5880.510.8415empty

Interfaces

1 interface between chains.

  • A–B · 927 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 3SZL · IspH:Ligand Mutants - wt 70sec · the same entry in another collection · chain A against A, TM-score 1.00
  • P62623 · AlphaFold monomer V2.0 prediction for 4-hydroxy-3-methylbut-2-enyl diphosphate reductase… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.